Impact of Standardized Skin-to-Skin Care on Clinical Outcomes in Infants Born ≤ 32 Weeks: A Multicenter Study

NCT06672913 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2024-11-04

No results posted yet for this study

Summary

This study is a multi-center, prospective pre-post clinical study conducted under the leadership of the Turkish Neonatal Society. It aims to investigate the effects of a standardized skin-to-skin care in NICU, initiated early and applied regularly, on recieving exclusive mothers' milk at discharge and clinical outcomes for preterm infants born ≤ 32 weeks of gestation.

1. Primary Objective: To evaluate the rate of receiving exclusive mothers' milk at discharge for infants born ≤ 32 weeks of gestation who have received skin-to-skin care in accordance with the study protocol.
2. Secondary Objective: To evaluate the rates of neonatal sepsis, intraventricular hemorrhage, and necrotizing enterocolitis (stage 2 and above) as well as the length of hospital stay for infants born at or below 32 weeks of gestation who have received skin-to-skin care in accordance with the study protocol.

Conditions

  • Premature
  • Skin to Skin Contact
  • Breast Feeding
  • Necrotizing Enterocolitis
  • Retinopathy of Prematurity

Interventions

BEHAVIORAL

skin to skin contact care

Early and regular skin to skin contact in NICU GA: \< 28 weeks: After the 72nd hour GA: 28 - 32 weeks: As soon as stabilization is ensured

Sponsors & Collaborators

  • Ankara University

    collaborator OTHER
  • Gazi University

    collaborator OTHER
  • Hacettepe University

    collaborator OTHER
  • Marmara University

    collaborator OTHER
  • Umraniye Education and Research Hospital

    collaborator OTHER_GOV
  • Trakya University

    collaborator OTHER
  • Ege University

    collaborator OTHER
  • Ondokuz Mayıs University

    collaborator OTHER
  • Cukurova University

    collaborator OTHER
  • Sanliurfa Harran University

    collaborator UNKNOWN
  • Cumhuriyet University

    collaborator OTHER
  • Uludag University

    collaborator OTHER
  • Kocaeli University

    collaborator OTHER
  • Aydin Adnan Menderes University

    collaborator OTHER
  • Konya City Hospital

    collaborator OTHER
  • Baskent University

    collaborator OTHER
  • Baskent University Ankara Hospital

    lead OTHER

Principal Investigators

  • Esin Koc, Prof, MD · Gazi University

  • Saadet Arsan, Prof, MD · Ankara University

  • Hülya Bilgen, Prof, MD · Marmara University

  • İlke Mungan Akın, Prof, MD · Umraniye Teaching and Research Hospital

  • Betül Acunaş, Prof, MD · Trakya University

  • Mehmet Yalaz, Prof, MD · Ege University

  • Sezin Unal, Prof, MD · Baskent University

  • Sule Yigit, Prof, MD · Hacettepe University

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Day
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-01
Primary Completion
2025-04-01
Completion
2025-06-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06672913 on ClinicalTrials.gov